These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4163329)

  • 21. [The effect of anticoagulant therapy in patients with congestive cardiomyopathy].
    Polić S; Rumboldt Z; Bagatin J; Metlicić S; Rakić D; Vucenik I
    Lijec Vjesn; 1988; 110(1-2):9-12. PubMed ID: 3283487
    [No Abstract]   [Full Text] [Related]  

  • 22. Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    J Neurosci Res; 1984; 12(2-3):493-8. PubMed ID: 6389896
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prothrombin time and heparin time during pelentan therapy].
    CERMAK L; HOBZA A; POKORNY J
    Pol Tyg Lek (Wars); 1956 Sep; 11(37):1577-8. PubMed ID: 13388837
    [No Abstract]   [Full Text] [Related]  

  • 24. CANCER INCIDENCE AND MORTALITY IN PATIENTS HAVING ANTICOAGULANT THERAPY.
    MICHAELS L
    Lancet; 1964 Oct; 2(7364):832-5. PubMed ID: 14197157
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experience with prophylactic postoperative anticoagulant treatment in 6551 patients].
    Alánt O; Alexy G
    Acta Chir Acad Sci Hung; 1969; 10(2):139-50. PubMed ID: 5344314
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction.
    Azar AJ; Koudstaal PJ; Wintzen AR; van Bergen PF; Jonker JJ; Deckers JW
    Ann Neurol; 1996 Mar; 39(3):301-7. PubMed ID: 8602748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Our experiences with long-term treatment with Pelentan in myocardial infarct].
    Argalás K; Rysavý F
    Vnitr Lek; 1968 Mar; 14(3):283-90. PubMed ID: 5638966
    [No Abstract]   [Full Text] [Related]  

  • 28. [An analysis of 1000 consecutive patients with acute cerebrovascular disease. The registry of cerebrovascular disease of La Alianza-Hospital Central of Barcelona].
    Arboix A; Massons J; Oliveres M; García L; Titus F
    Med Clin (Barc); 1993 Sep; 101(8):281-5. PubMed ID: 8377532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the changes in the blood coagulation system in the dynamics of treating ischemic insult with anticoagulants].
    Lobkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):645-51. PubMed ID: 4268851
    [No Abstract]   [Full Text] [Related]  

  • 30. [The combination theory of the pathogenesis of atherosclerosis of the lower limbs and new perspectives in its therapy].
    Eristavi KD; Machabeli MS
    Khirurgiia (Mosk); 1965 Dec; 41(12):9-14. PubMed ID: 5878886
    [No Abstract]   [Full Text] [Related]  

  • 31. A long term study of cerebral vascular disease.
    Groch SN; McDevitt E; Wright IS
    Res Publ Assoc Res Nerv Ment Dis; 1966; 41():303-17. PubMed ID: 4163328
    [No Abstract]   [Full Text] [Related]  

  • 32. USE OF ANTICOAGULANTS: PRO AND CON.
    OCHSNER A; QUICK AJ; PAUL O; JULIAN OC; OLWIN JH
    Postgrad Med; 1964 Jun; 35():629-37. PubMed ID: 14143307
    [No Abstract]   [Full Text] [Related]  

  • 33. CEREBRAL VASCULAR INSUFFICIENCY.
    HURWITZ LJ
    Gerontol Clin (Basel); 1964; 6():81-92. PubMed ID: 14102816
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anticoagulant treatment following thrombolytic therapy].
    Ohler WG
    Med Klin; 1966 Jan; 61(4):140-2. PubMed ID: 5983159
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our experience with postoperative preventive anticoagulant treatment. Apropos of 348 pneumonectomies].
    Gaillard J; Eschapasse H; Bierme R; Henry E; Boneu B; Marschal J
    Ann Chir Thorac Cardiovasc; 1971 Jul; 10(3):339-47. PubMed ID: 5569097
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical, laboratory and animal experimental observations in treating 288 cases of ischemic cerebrovascular disease with polysaccharide sulfate].
    Han ZY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):99-103, 127. PubMed ID: 2571468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of carbohydrate-phosphorus metabolism in erythrocytes of patients with acute cerebrovascular disorders].
    Lobanova ND
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1327-31. PubMed ID: 4659410
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of cerebral ictus yesterday and today].
    Giorgini R
    Minerva Med; 1974 Mar; 65(24):1316-21. PubMed ID: 4133959
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of long-term anticoagulant therapy in cerebral circulatory disorders].
    Lehmann H; Fiegle B; Held K
    Verh Dtsch Ges Inn Med; 1972; 78():675-7. PubMed ID: 4665726
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
    Dordević BS; Bosnjaković V; Baklaja-Jevremović R; Nastić D
    Acta Med Iugosl; 1970; 24(1):7-19. PubMed ID: 5201592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.